VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Gotta love this paragraph...

<< Previous

Bullboard Posts

Next >>

Comment by InvrsContrarianon Sep 15, 2021 10:56pm

138 Views

Post# 33866994

RE:Gotta love this paragraph...

Yes that stuck out to me too!

Yajne wrote: from GA's letter after update #1, and the anticipated launch from GEHC [GE Health Care]. Lot's to look forward to here...unless you simply don't believe GA.....I do. GLTA longs!

"I know everyone wants to hear more about the GEHC collaboration, but they have muzzled us as they want the launch to be a big surprise and view any news as competitive information. Elephants are like that! As I have said before - you do not take an elephant for a walk, the elephant takes you for a walk."